Close

AMAG Pharma (AMAG) Reports Q3 EPS of 6c

October 30, 2014 7:50 AM EDT

AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of $0.06, may not compare the analyst estimate of ($0.08). Revenue for the quarter came in at $25.5 million versus the consensus estimate of $26.3 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings